QuantAbundanciaAbundance, Quantified.

News

High-signal headlines only - macro events, earnings, M&A, regulatory. Listicles and analyst clickbait filtered out by default. Refreshed hourly.

22,335 signal articles · 399 in last 24h · 107,361 total before filter · latest 28m ago
399last 24h
2518last 7d
492● bullish (7d)
239● bearish (7d)
200publishers
AllMacro215Earnings1555M&A124Regulatory16Product9Analyst25
✕ clear all filtersSentiment:bullishneutralbearishshow all (incl. clickbait)
Treasury Yields Rise Ahead of First Fed Decision Under Warsh
Barrons.com51d agoneutral
Treasury Yields Rise Ahead of First Fed Decision Under Warsh

Treasury yields tick higher ahead of the first interest rate decision under Fed Chairman Kevin Warsh. Rates are expected to remain unchanged. Investors are curious about how Warsh will change the central bank's communications with the public and its forward guidance.

Micron Stock Rebounds But Memory-Chip Frenzy Faces a Fed Test
Barrons.com51d agoneutral
Micron Stock Rebounds But Memory-Chip Frenzy Faces a Fed Test

Micron Technology stock was back on the rise early Wednesday as the memory-chip maker looks to resume its relentless rally. Micron was leading the rebound in premarket trading, rising 3.5%, the second-best performer in the Only Intel was climbing more ahead of the open. When there’s nothing happening Micron stock tends to gain.

Big pharma taps UK playbook to pressure Europe on drug prices
Reuters Videos51d agoneutralVIDEO
Big pharma taps UK playbook to pressure Europe on drug prices

<body><p>STORY: Big pharma is receiving pushback from European capitals on drug pricing.&nbsp;</p><p>So they’re turning to a playbook that brought them success in the UK.</p><p>Making threats to pull investment plans to pressure policymakers.&nbsp;</p><p>The industry notched a win when the British government agreed to increase medicine spending as part of a broader deal to avoid U.S.-imposed tariffs.&nbsp;</p><p>The latest nation to face pressure is Germany, which has been debating legislation to tighten spending on medicines.&nbsp;</p><p>A Reuters European Pharma correspondent Maggie Fick said pressure in the last week has ramped up.&nbsp;</p><p>"The CEO of Pfizer wrote a letter to the German chancellor warning that their future investments in the country may be at risk over these proposed changes to pricing laws."</p><p>Meanwhile, AstraZeneca warned that it may not launch new medicines in Germany if these changes go ahead.</p><p>Earlier in June, Eli Lilly announced it would halve a planned $2.7 billion investment, also citing the proposed legislation.&nbsp;</p><p>This bid to cap costs has centered Germany in a broader tussle between drugmakers and European governments that began several months ago.</p><p>That tension has been sharpened by the impact on Europe of U.S. President Donald Trump's pricing push.</p><p>This aims to tie prescription medicine prices in the lucrative U.S. market to ​lower prices elsewhere, including in Europe.</p><p>Major drugmakers have struck deals with the White House to lower drug costs in exchange for tariff exemptions, adding to pressure for increasing prices elsewhere.</p></body>

WeRide and Uber Target Zurich Robotaxi Launch as European Expansion Accelerates
InvestorsHub51d agoneutral
WeRide and Uber Target Zurich Robotaxi Launch as European Expansion Accelerates

WeRide (NASDAQ:WRD) and Uber Technologies (NYSE:UBER) plan to introduce commercial robotaxi services in the Greater Zurich Region later this year, extending their autonomous mobility partnership in Europe following a recent deployment announcement in Madrid. The service is expected to launch during 2026, pending approval from Switzerland’s Federal Roads Office (FEDRO).

Investing.com51d agoneutral
Trump supports Canada’s Chinese EV import cap arrangement, Carney says

Investing.com -- President Donald Trump expressed approval of Canada's agreement with China that limits Chinese electric vehicle imports through a quota system with reduced tariffs, Canadian Prime Minister Mark Carney said Wednesday at the Group of Seven leaders summit in Evian, France.

Nasdaq Futures Rising as Iran Peace Deal Boosts the Market Ahead of Fed Decision
Barrons.com51d agoneutral
Nasdaq Futures Rising as Iran Peace Deal Boosts the Market Ahead of Fed Decision

Stocks were on track to rise Wednesday after more details about the U.S.-Iran peace deal leaked, bolstering hopes that the two countries are on the brink of reaching an agreement to end the war in the Middle East. Futures tracking the tech-heavy Nasdaq 100 gained 0.5%, while S&P 500 futures added 0.1%. The market looked set for a broader rally on Wednesday after The Wall Street Journal reported that the U.S. would allow Iran to immediately begin selling oil and fuel under the deal to end the war, citing people familiar with the agreement.

Will Kevin Warsh Trigger a Bitcoin Selloff Today?
Trefis51d agobearish
Will Kevin Warsh Trigger a Bitcoin Selloff Today?

Bitcoin is trading at approximately $65,829 as Federal Reserve Chair Kevin Warsh steps in to chair his first FOMC meeting. While traders analyzing whether the central bank will hike or hold this Wednesday have priced in a 3.50-3.75% rate hold at a 97.4% probability per the CME FedWatch tool, the true market driver remains Warsh’s impending forward guidance.

Bloomberg51d agobullish
Bond Rally Fails to Allay Higher-for-Longer Global Rates Threat

(Bloomberg) -- Governments around the world look to be facing lofty borrowing costs for at least the rest of the year, even as the fragile Middle East truce lowers energy prices and curbs inflationary fears.Most Read from BloombergRead the 14-Point Draft Memorandum Between the US and IranIran’s Deputy Foreign Minister Confirms Deal Reached With USModi Warns of ‘Shortage of Trust’ Ahead of Trump MeetingNetanyahu Pays a Political Price for Trump’s Iran DealUS Set to Offer Iran Broad Financial Gain

SpaceX Drives 'Historic' Surge In Tokenized Stock Trading, Market Commentator Says: 'Solana Dwarfed All Other Chains'
Benzinga51d agobullish
SpaceX Drives 'Historic' Surge In Tokenized Stock Trading, Market Commentator Says: 'Solana Dwarfed All Other Chains'

Market commentator The Kobeissi Letter highlighted on Tuesday a record surge in tokenized stocks on Solana (CRYPTO: SOL), led by strong demand following Space Exploration Technologies Corp. (NASDAQ:SPCX)‘s blockbuster IPO. SpaceX Accelerates Tokenization Push Kobeissi Letter drew attention to $4.3 billion in on-chain volume of tokenized stocks over the last 30 days, citing data from asset tokenization analytics platform rwa.xyz. This marked the highest monthly volume ever, and a 140% year-to-dat